Literature DB >> 31657733

Public health implications of legalising the production and sale of cannabis for medicinal and recreational use.

Wayne Hall1, Daniel Stjepanović2, Jonathan Caulkins3, Michael Lynskey4, Janni Leung5, Gabrielle Campbell6, Louisa Degenhardt6.   

Abstract

We assess the current and describe possible future public health impacts of the legalisation of cannabis production, sale, and use in the Americas. First, we describe global patterns of cannabis use and their most probable adverse health effects. Second, we summarise evidence regarding the effectiveness of cannabinoids for medicinal use and describe approaches that have been used to regulate the use of medicinal cannabis and how these approaches might have affected medicinal and recreational use and harms (eg, road crashes). Third, we describe how jurisdictions that have legalised recreational use have regulated production and sale of cannabis. Fourth, we evaluate the effects of cannabis legalisation on cannabis use and harms and on the use of alcohol, tobacco, and other drugs. Fifth, we use alcohol and tobacco policy examples to identify possible long-term public health effects of cannabis legalisation. Finally, we outline policy approaches that could minimise harms to public health arising from the legalisation of a commercial cannabis industry.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31657733     DOI: 10.1016/S0140-6736(19)31789-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  51 in total

Review 1.  Cannabis use and cannabis use disorder.

Authors:  Jason P Connor; Daniel Stjepanović; Bernard Le Foll; Eva Hoch; Alan J Budney; Wayne D Hall
Journal:  Nat Rev Dis Primers       Date:  2021-02-25       Impact factor: 52.329

Review 2.  Is legalization of recreational cannabis associated with levels of use and cannabis use disorder among youth in the United States? A rapid systematic review.

Authors:  Megan A O'Grady; Marissa G Iverson; Adekemi O Suleiman; Taeho Greg Rhee
Journal:  Eur Child Adolesc Psychiatry       Date:  2022-05-04       Impact factor: 4.785

3.  Global patterns of opioid use and dependence: harms to populations, interventions, and future action.

Authors:  Louisa Degenhardt; Jason Grebely; Jack Stone; Matthew Hickman; Peter Vickerman; Brandon D L Marshall; Julie Bruneau; Frederick L Altice; Graeme Henderson; Afarin Rahimi-Movaghar; Sarah Larney
Journal:  Lancet       Date:  2019-10-23       Impact factor: 79.321

4.  Characterization of substance use among underrepresented sexual and gender minority participants in The Population Research in Identity and Disparities for Equality (PRIDE) Study.

Authors:  Branden T Barger; Juno Obedin-Maliver; Matthew R Capriotti; Mitchell R Lunn; Annesa Flentje
Journal:  Subst Abus       Date:  2020-02-07       Impact factor: 3.716

5.  Road Safety Risks of Cannabis Use: Sales Need to Fund Research.

Authors:  Wayne Hall; Tyler Lane
Journal:  Am J Public Health       Date:  2020-03       Impact factor: 9.308

Review 6.  Cannabis and driving ability.

Authors:  Eric L Sevigny
Journal:  Curr Opin Psychol       Date:  2021-03-17

7.  Current U.S. State Cannabis Sales Limits Allow Large Doses for Use or Diversion.

Authors:  Rosalie Liccardo Pacula; Jason G Blanchette; Marlene C Lira; Rosanna Smart; Timothy S Naimi
Journal:  Am J Prev Med       Date:  2021-02-12       Impact factor: 5.043

Review 8.  Down and High: Reflections Regarding Depression and Cannabis.

Authors:  Catherine Langlois; Stéphane Potvin; Atul Khullar; Smadar Valérie Tourjman
Journal:  Front Psychiatry       Date:  2021-05-14       Impact factor: 4.157

9.  Modes of delivery in concurrent nicotine and cannabis use ("co-use") among youth: Findings from the International Tobacco Control (ITC) Survey.

Authors:  Danielle M Smith; Connor Miller; Richard J O'Connor; Lynn T Kozlowski; Elle Wadsworth; Brian V Fix; R Lorraine Collins; Binnian Wei; Maciej L Goniewicz; Andrew J Hyland; David Hammond
Journal:  Subst Abus       Date:  2020-01-17       Impact factor: 3.716

10.  International Association for the Study of Pain Presidential Task Force on Cannabis and Cannabinoid Analgesia: research agenda on the use of cannabinoids, cannabis, and cannabis-based medicines for pain management.

Authors:  Simon Haroutounian; Lars Arendt-Nielsen; Joletta Belton; Fiona M Blyth; Louisa Degenhardt; Marta Di Forti; Christopher Eccleston; David P Finn; Nanna B Finnerup; Emma Fisher; Alexandra E Fogarty; Ian Gilron; Andrea G Hohmann; Eija Kalso; Elliot Krane; Mohammed Mohiuddin; R Andrew Moore; Michael Rowbotham; Nadia Soliman; Mark Wallace; Nantthasorn Zinboonyahgoon; Andrew S C Rice
Journal:  Pain       Date:  2021-07-01       Impact factor: 6.961

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.